Biochem Pharmacol

1. ISHIOH M, Nozu T, Ohgidani M, Furube E, et al
   beta-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats.
   Biochem Pharmacol. 2026;250.
   

   >> Share

   
   

   
   bioRxiv

2. MULLER E, Baum S, Borenstein E
   MAAMOUL: Metabolic network-based discovery of microbiome-metabolome shifts in disease.
   bioRxiv [Preprint]. 2026 Mar 30:2026.03.27.714614.
   

   >> Share

   
   

   
   BMJ Case Rep

3. HEBDEN LA, Sreh A, Hebden JM
   Functional bowel disease symptoms and a de novo raised carcinoembryonic antigen: delayed diagnosis of medullary cell thyroid carcinoma.
   BMJ Case Rep. 2026;19:e270871.
   

   >> Share

   
   

   
   Brain Imaging Behav

4. REISIAN M, Toben C, Ciobanu LG, Jawahar MC, et al
   A systematic review of associations between functional connectivity, mood and cognition in patients with irritable bowel syndrome.
   Brain Imaging Behav. 2026;20:71.
   

   >> Share

   
   

   
   Commun Med (Lond)

5. MEHRAVAR S, Yeo YH, Pimentel M, Naji P, et al
   Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome.
   Commun Med (Lond). 2026;6:176.
   

   >> Share

   
   

   
   Curr Protein Pept Sci

6. THOMBRE KR, Rahangdale ND, Gupta KR, Umekar MJ, et al
   Neuropeptide Y Receptor Modulators in Gut Physiology and Therapy.
   Curr Protein Pept Sci. 2026 Mar 18. doi: 10.2174/0113892037432130260204153437.
   

   >> Share

   
   

   
   Front Immunol

7. EL-SAADONY MT, Saad AM, Sitohy M, Alkafaas SS, et al
   Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review.
   Front Immunol. 2026;16:1713426.
   

   >> Share

   
   

   
   Front Med (Lausanne)

8. TIAN D, Liu X, Qiao H, Liu F, et al
   Map the prevalence of irritable bowel syndrome across China: a systematic review and meta-analysis.
   Front Med (Lausanne). 2026;13:1740952.
   

   >> Share

   
   
9. LI S, Dong W, Chen X, Tan X, et al
   Association between ultra-processed food consumption and risk of irritable bowel syndrome and functional dyspepsia: a systematic review and meta-analysis of observational studies.
   Front Med (Lausanne). 2026;13:1780040.
   

   >> Share

   
   
10. XU C, Shi Y, Huang W, Zhuang H, et al
    Cultural adaptation and psychometric validation of the Gastrointestinal Unhelpful Thinking Scale.
    Front Med (Lausanne). 2026;13:1807329.
    

    >> Share

    
    

    
    Gastro Hep Adv

11. PELLETIER K, Villarreal M, Klar R, Chey WD, et al
    Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Reintroduction in Clinical Practice: Surveying the Gaps and Opportunities.
    Gastro Hep Adv. 2026;5:100908.
    

    >> Share

    
    

    
    J Neurogastroenterol Motil

12. LI C, Liu Q, Cao J, Xu X, et al
    Patients' Knowledge, Attitudes, and Practices Regarding Non-pharmacological Treatments for Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2026;32:276-289.
    

    >> Share

    
    
13. EL-SALHY M, Corsetti M, Gilja OH, Gonlachanvit S, et al
    Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2026;32:185-197.
    

    >> Share

    
    
14. KIM JW
    From Belief to Behavior: Closing the Knowledge-Practice Gap in Irritable Bowel Syndrome Self-management.
    J Neurogastroenterol Motil. 2026;32:145-147.
    

    >> Share

    
    

    
    JGH Open

15. NISHIDA T, Osugi N, Amano T, Yoshihara T, et al
    Selective Drug-Free Active Surveillance in Ulcerative Colitis: Biomarker-Guided, Patient-Centered Approach.
    JGH Open. 2026;10:e70399.
    

    >> Share

    
    

    
    Neurogastroenterol Motil

16. WUESTENBERGHS F, Jouet P, Piche T, Mion F, et al
    Impact of Early-Onset IBS on Schooling, Illness in Adulthood, and Career Prospects.
    Neurogastroenterol Motil. 2026;38:e70308.
    

    >> Share

    
    
17. KULIN D, Shah A, Fairlie T, Staller K, et al
    Gastrointestinal Symptoms and Systemic Comorbidities in Patients With POTS: A Systematic Review and Meta-Analysis.
    Neurogastroenterol Motil. 2026;38:e70305.
    

    >> Share

    
    

    
    Res Sq

18. AZIZ NI, Rahim A, Azam SI, Butt AS, et al
    Frequency of Functional Gastrointestinal Disorders and association with occupational stress among nurses at a tertiary care hospital in Karachi, Pakistan: an analytical cross-sectional study.
    Res Sq [Preprint]. 2026 Apr 1:rs.3.rs-9219713. doi: 10.21203/rs.3.rs-9219713.
    

    >> Share

    
    

    
    Saudi J Gastroenterol

19. ALZAHRANI MA, Alzubide SR, Abufarhaneh E, Alqaraawi AM, et al
    Saudi consensus statements on the management of irritable bowel syndrome.
    Saudi J Gastroenterol. 2026 Apr 8. doi: 10.4103.
    

    >> Share

    
    

    
    Ther Adv Gastroenterol

20. WEI Y, Shi Z, Wu S, Yao X, et al
    Efficacy and safety of non-invasive transcutaneous nerve stimulation in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Ther Adv Gastroenterol. 2026;19:17562848261436121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share